Olivier Gribouval1, Olivia Boyer1,2, Bertrand Knebelmann3, Alexandre Karras4, Jacques Dantal5, Cécile Fourrage6, Olivier Alibeu7, Julien Hogan8, Claire Dossier8, Marie Josèphe Tête1, Corinne Antignac1,9, Aude Servais1,3. 1. Inserm U1163, Institut Imagine, University Paris Descartes, Paris, France. 2. Pediatric Nephrology Department, Necker Hospital, APHP, Paris, France. 3. Nephrology and Transplantation Department, Necker Hospital, APHP, Paris, France. 4. Nephrology Department, European Georges Pompidou Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France. 5. Nephrology Department, Centre Hospitalier Universitaire de Nantes, Nantes, France. 6. Bioinformatic Platform, Paris Descartes Sorbonne Paris Cité University, Imagine Institute, Paris, France. 7. Genomic Platform, Inserm UMR1163, Paris Descartes Sorbonne Paris Cité University, Paris, France. 8. Pediatric Nephrology Department, Robert Debré Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France. 9. Genetic Department, Necker Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
Abstract
BACKGROUND: Apolipoprotein L1 (APOL1) risk variants are strongly associated with sporadic focal segmental glomerulosclerosis (FSGS) in populations with African ancestry. We determined the frequency of G1/G2 variants in steroid-resistant nephrotic syndrome (SRNS)/FSGS patients with African or French West Indies ancestry in France and its relationships with other SRNS genes. METHODS: In a cohort of 152 patients (139 families), the APOL1 risk variants were genotyped by direct Sanger sequencing and pathogenic mutations were screened by next-generation sequencing with a panel including 35 SRNS genes. RESULTS: The two risk allele [high-risk (HR)] genotypes were found in 43.1% (66/152) of subjects compared with 18.9% (106/562) in a control population (P < 0.0001): 33 patients homozygous for APOL1 G1 alleles, 4 homozygous for G2 and 29 compound heterozygous for G1 and G2. Compared with patients in the low-risk (LR) group, patients in the HR group were more likely to originate from the French West Indies than from Africa [45/66 (68.2%) versus 30/86 (34.9%); P < 0.0001]. There were more familial cases in the HR group [27 (41.5%) versus 8 (11.4%); P < 0.0001]. However, causative mutations in monogenic SRNS genes were found in only 1 patient in the HR group compared with 16 patients (14 families) in the LR group (P = 0.0006). At diagnosis, patients in the HR group without other mutations were more often adults [35 (53.8%) versus 19 (27.1%); P = 0.003] and had a lower estimated glomerular filtration rate (78.9 versus 98.8 mL/min/1.73 m2; P = 0.02). CONCLUSIONS: The HR genotype is frequent in FSGS patients with African ancestry in our cohort, especially in those originating from the West Indies, and confer a poor renal prognosis. It is usually not associated with other causative mutations in monogenic SRNS genes.
BACKGROUND:Apolipoprotein L1 (APOL1) risk variants are strongly associated with sporadic focal segmental glomerulosclerosis (FSGS) in populations with African ancestry. We determined the frequency of G1/G2 variants in steroid-resistant nephrotic syndrome (SRNS)/FSGS patients with African or French West Indies ancestry in France and its relationships with other SRNS genes. METHODS: In a cohort of 152 patients (139 families), the APOL1 risk variants were genotyped by direct Sanger sequencing and pathogenic mutations were screened by next-generation sequencing with a panel including 35 SRNS genes. RESULTS: The two risk allele [high-risk (HR)] genotypes were found in 43.1% (66/152) of subjects compared with 18.9% (106/562) in a control population (P < 0.0001): 33 patients homozygous for APOL1 G1 alleles, 4 homozygous for G2 and 29 compound heterozygous for G1 and G2. Compared with patients in the low-risk (LR) group, patients in the HR group were more likely to originate from the French West Indies than from Africa [45/66 (68.2%) versus 30/86 (34.9%); P < 0.0001]. There were more familial cases in the HR group [27 (41.5%) versus 8 (11.4%); P < 0.0001]. However, causative mutations in monogenic SRNS genes were found in only 1 patient in the HR group compared with 16 patients (14 families) in the LR group (P = 0.0006). At diagnosis, patients in the HR group without other mutations were more often adults [35 (53.8%) versus 19 (27.1%); P = 0.003] and had a lower estimated glomerular filtration rate (78.9 versus 98.8 mL/min/1.73 m2; P = 0.02). CONCLUSIONS: The HR genotype is frequent in FSGS patients with African ancestry in our cohort, especially in those originating from the West Indies, and confer a poor renal prognosis. It is usually not associated with other causative mutations in monogenic SRNS genes.
Authors: Mariam Aghajan; Sheri L Booten; Magnus Althage; Christopher E Hart; Anette Ericsson; Ingela Maxvall; Joseph Ochaba; Angela Menschik-Lundin; Judith Hartleib; Steven Kuntz; Danielle Gattis; Christine Ahlström; Andrew T Watt; Jeffery A Engelhardt; Brett P Monia; Maria Chiara Magnone; Shuling Guo Journal: JCI Insight Date: 2019-06-20
Authors: Rachel K Y Hung; Elizabeth Binns-Roemer; John W Booth; Rachel Hilton; Mark Harber; Beatriz Santana-Suarez; Lucy Campbell; Julie Fox; Andrew Ustianowski; Catherine Cosgrove; James E Burns; Amanda Clarke; David A Price; David Chadwick; Denis Onyango; Lisa Hamzah; Kate Bramham; Caroline A Sabin; Cheryl A Winkler; Frank A Post Journal: Kidney Int Rep Date: 2022-01-25
Authors: Amanda P Waller; Shipra Agrawal; Katelyn J Wolfgang; Jiro Kino; Melinda A Chanley; William E Smoyer; Bryce A Kerlin Journal: Physiol Rep Date: 2020-08